全文获取类型
收费全文 | 22148篇 |
免费 | 2147篇 |
国内免费 | 27篇 |
专业分类
耳鼻咽喉 | 384篇 |
儿科学 | 640篇 |
妇产科学 | 607篇 |
基础医学 | 2993篇 |
口腔科学 | 679篇 |
临床医学 | 2932篇 |
内科学 | 4124篇 |
皮肤病学 | 410篇 |
神经病学 | 1752篇 |
特种医学 | 789篇 |
外国民族医学 | 2篇 |
外科学 | 3183篇 |
综合类 | 353篇 |
一般理论 | 13篇 |
预防医学 | 2112篇 |
眼科学 | 406篇 |
药学 | 1529篇 |
3篇 | |
中国医学 | 58篇 |
肿瘤学 | 1353篇 |
出版年
2021年 | 193篇 |
2020年 | 192篇 |
2019年 | 285篇 |
2018年 | 356篇 |
2017年 | 263篇 |
2016年 | 291篇 |
2015年 | 351篇 |
2014年 | 515篇 |
2013年 | 733篇 |
2012年 | 1046篇 |
2011年 | 1145篇 |
2010年 | 626篇 |
2009年 | 525篇 |
2008年 | 938篇 |
2007年 | 967篇 |
2006年 | 1008篇 |
2005年 | 921篇 |
2004年 | 1024篇 |
2003年 | 965篇 |
2002年 | 828篇 |
2001年 | 765篇 |
2000年 | 691篇 |
1999年 | 660篇 |
1998年 | 255篇 |
1997年 | 202篇 |
1996年 | 188篇 |
1995年 | 205篇 |
1994年 | 179篇 |
1993年 | 186篇 |
1992年 | 520篇 |
1991年 | 516篇 |
1990年 | 445篇 |
1989年 | 505篇 |
1988年 | 473篇 |
1987年 | 465篇 |
1986年 | 444篇 |
1985年 | 469篇 |
1984年 | 315篇 |
1983年 | 280篇 |
1982年 | 194篇 |
1981年 | 174篇 |
1979年 | 254篇 |
1978年 | 196篇 |
1977年 | 162篇 |
1976年 | 176篇 |
1975年 | 154篇 |
1974年 | 188篇 |
1973年 | 202篇 |
1972年 | 158篇 |
1971年 | 161篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Clark Hannah Rana Rezwanul Gow Jeff Pearson Melissa van der Touw Tom Smart Neil 《Heart failure reviews》2022,27(2):559-572
Heart Failure Reviews - Heart failure with preserved ejection fraction (HFpEF) is problematic to treat, with guidelines for HFpEF management concentrated on treating prevalent comorbidities. The... 相似文献
2.
Paula Pessin Fábrega Branisso Claudia Pinto Marques Souza de Oliveira Hilton Muniz Leão Filho Fabiana Roberto Lima Aritânia Sousa Santos Marcio Correa Mancini Maria Edna de Melo Flair José Carrilho Manoel de Souza Rocha Paul Clark Henrique José Pereira Branisso Cintia Cercato 《Annals of hepatology》2022,27(4):100707
IntroductionAlthough hyperferritinemia may reflect the inflammatory status of patients with non-alcoholic fatty liver disease (NAFLD), approximately 33% of hyperferritinemia cases reflect real hepatic iron overload.AimTo evaluate a non-invasive method for assessing mild iron overload in patients with NAFLD using 3T magnetic resonance imaging (MRI) relaxometry, serum hepcidin, and the expression of ferritin subunits.MethodsThis cross-sectional study assessed patients with biopsy-proven NAFLD. MRI relaxometry was performed using a 3T scanner in all patients, and the results were compared with iron content determined by liver biopsy. Ferritin, hepcidin, and ferritin subunits were assessed and classified according to ferritin levels and to siderosis identified by liver biopsy.ResultsA total of 67 patients with NAFLD were included in the study. MRI revealed mild iron overload in all patients (sensitivity, 73.5%; specificity, 70%). For mild (grade 1) siderosis, the transverse relaxation rate (R2*) threshold was 58.9 s?1 and the mean value was 72.5 s?1 (SD, 33.9), while for grades 2/3 it was 88.2 s?1 (SD, 31.9) (p < 0.001). The hepcidin threshold for siderosis was > 30.2 ng/mL (sensitivity, 87%; specificity, 82%). Ferritin H and ferritin L subunits were expressed similarly in patients with NAFLD, regardless of siderosis. There were no significant differences in laboratory test results between the groups, including glucose parameters and liver function tests.ConclusionsMRI relaxometry and serum hepcidin accurately assessed mild iron overload in patients with dysmetabolic iron overload syndrome. 相似文献
3.
Peter P. Hsiue Troy Sekimura Alfonso Ocampo Clark J. Chen Thomas E. Olson Benjamin V. Kelley Christos Photopoulos Alexandra I. Stavrakis 《Seminars in Arthroplasty》2022,32(2):297-304
BackgroundRenal disease including chronic renal disease and end-stage renal disease has been associated with the development of primary glenohumeral osteoarthritis. However, little is known about how renal disease affects outcomes after shoulder arthroplasty. Thus, the purpose of this study was to evaluate the impact of renal disease on outcomes of shoulder arthroplasty for glenohumeral osteoarthritis.MethodsThis was a retrospective review using the Nationwide Readmissions Database. Using International Classification of Diseases, 9th Revision, codes, patients who underwent shoulder arthroplasty (including total shoulder arthroplasty and reverse total shoulder arthroplasty) for primary glenohumeral osteoarthritis were identified. These patients were divided into 3 groups: no renal disease, predialysis chronic renal disease (including stages 1-5), and end-stage renal disease. Primary outcomes of interest included the risk of complications during index hospitalization as well as within 90 days of index surgery. Secondary outcomes included index hospitalization length of stay, cost, and discharge location.ResultsFrom 2010 to 2014, a total of 29,336 patients underwent shoulder arthroplasty for glenohumeral osteoarthritis. Of these 29,336, 27,928 (95.2%) patients had no renal disease, 1355 (4.6%) had predialysis chronic renal disease, and 53 (0.2%) patients had end-stage renal disease. Compared with patients with no renal disease, both predialysis chronic renal disease and end-stage renal disease patients had an increased risk of receiving blood transfusions (odds ratio [OR] = 2.04, P < .0001, and 5.37, P = .04, respectively) and experiencing any postoperative complication during the index hospitalization (OR = 2.31, P < .0001, and 3.94, P = .003, respectively). Specifically, predialysis chronic renal disease patients were at an increased risk for cardiac (OR = 1.96, P < .0001) and respiratory (OR = 1.55, P < .0001) complications as well as acute renal failure (OR = 14.70, P < .0001) postoperatively. End-stage renal disease patients were at an increased risk for cardiac (OR = 3.87, P = .003) complications as well as acute renal failure (OR = 10.35, P = .002) postoperatively. Within 90 days, end-stage renal disease patients had an increased risk of hospital readmission (OR = 8.01, P < .0001), dislocation (OR = 8.70, P = .039), and surgical site infection (OR = 19.06, P = .001). Finally, compared with patients with no renal disease, predialysis chronic renal disease and end-stage renal disease patients both had increased hospital length of stay and cost; predialysis chronic renal disease patients had an increased risk of discharge to a skilled nursing facility (OR = 1.39, P = .039).Discussion and ConclusionThis retrospective cohort study demonstrates that even predialysis chronic renal disease patients have worse outcomes compared with patients with no renal disease after shoulder arthroplasty for glenohumeral osteoarthritis. These findings serve to highlight the importance of close perioperative monitoring to prevent complications in a potentially overlooked patient population. 相似文献
4.
5.
Taye Belaynew W. Valery Patricia C. Liddle Burglind Woodward Aidan J. Sackey Donata Williams Suzanne Chang Gary K. F. Clark Paul J. 《Journal of immigrant and minority health / Center for Minority Public Health》2022,24(5):1196-1205
Journal of Immigrant and Minority Health - This study explored the epidemiology and health literacy of people affected by viral hepatitis (VH) from migrant culturally and linguistically diverse... 相似文献
6.
McAllister Milly J. Kirkwood Kathryn Chuah Shaun C. Thompson Emily J. Cartwright Jennifer A. Russell Clark D. Dorward David A. Lucas Christopher D. Ho Gwo-tzer 《Inflammation》2022,45(2):567-572
Inflammation - The coronavirus SARS-CoV-2 contributes to morbidity and mortality mainly as a result of immune-pathology in the lungs. Recent data has shown multi-system involvement with widespread... 相似文献
7.
Peña Pino Isabela Ma Jun Hori Yusuke S. Fomchenko Elena Dusenbery Kathryn Reynolds Margaret Wilke Christopher Yuan Jianling Srinivasan Ethan Grabowski Matthew Fecci Peter Domingo-Musibay Evidio Fujioka Naomi Barnett Gene H. Chang Veronica Mohammadi Alireza M. Chen Clark C. 《Journal of neuro-oncology》2022,156(2):295-306
Journal of Neuro-Oncology - The optimal treatment paradigm for brain metastasis that recurs locally after initial radiosurgery remains an area of active investigation. Here, we report outcomes for... 相似文献
8.
9.
Rahele Ziaei Sahar Foshati Amir Hadi Mohamad Ail Hojati Kermani Abed Ghavami Cain C.T. Clark Mohammad Javad Tarrahi 《Phytotherapy research : PTR》2020,34(2):282-294
Type 2 diabetes mellitus (T2DM) is a major health problem, worldwide, that is associated with increased morbidity and mortality. Several randomized controlled clinical trials (RCTs) have investigated the effect of nettle (Urtica dioica) supplementation on markers of glycemic status in patients with T2DM, with conflicting results. Therefore, the present study assessed the effect of nettle on some glycemic parameters in patients with T2DM. A comprehensive search was conducted in PubMed, Scopus, Cochrane Library, and Web of Science, from database inception up to June 2019, to identify RCTs investigating the effect of nettle supplementation on glycemic markers, including fasting blood sugar (FBS) concentrations, insulin levels, homeostasis model assessment‐estimated insulin resistance index, and glycosylated hemoglobin percentage in adults with T2DM. The Cochrane Collaboration tool was used to assess the methodological quality of the included studies. Results of this meta‐analysis were reported based on the random effects model. Eight RCTs, comprising 401 participants, were included in the present systematic review and meta‐analysis. Based on the Cochrane Collaboration risk of bias tool, five studies were considered as good quality, one was fair, and two studies were poor, respectively. The results of the meta‐analysis revealed a significant reduction in FBS concentrations (weighted mean difference [WMD]: ?18.01 mg/dl, 95% confidence interval [CI]: ?30.04 to ?5.97, p < .001, I2 = 94.6%) following nettle supplementation. However, no significant reduction was observed in insulin levels (WMD: 0.83 Hedges' g, 95% CI: ?0.26 to 1.92, p = .13, I2 = 89.4%), homeostasis model assessment‐estimated insulin resistance index (WMD: ?0.22, 95% CI: ?0.83 to 0.40, p = .49, I2 = 69.2%), or glycosylated hemoglobin percentage (WMD: ?0.77%, 95% CI: ?1.77 to 0.22, p = .12, I2 = 83.0%). The findings of the present study suggest that nettle supplementation may be effective in controlling FBS for T2DM patients. However, further studies are needed to confirm the veracity of these results. 相似文献
10.
Konstantinos Chouliaras MD Rebecca Senehi MD Cecilia G. Ethun MD MS George Poultsides MD Thuy Tran MD Valerie Grignol MD Thomas Clark Gamblin MD Kevin K. Roggin MD Jennifer Tseng MD Ryan C. Fields MD Sharon M. Weber MD Gregory B. Russell MS Edward A. Levine MD Kenneth Cardona MD Konstantinos Votanopoulos MD 《Journal of surgical oncology》2019,120(3):340-347